Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
August 10, 2022 at 05:16 am EDT
Share
Autobio Diagnostics Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 2,070.25 million compared to CNY 1,677.58 million a year ago. Net income was CNY 533.52 million compared to CNY 412.68 million a year ago. Basic earnings per share from continuing operations was CNY 0.91 compared to CNY 0.7 a year ago. Diluted earnings per share from continuing operations was CNY 0.91 compared to CNY 0.7 a year ago.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.